Join
Live feed
·
PRReleasevia Quantisnow
BioCardia Inc. logo

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency

ByQuantisnow·Wall Street's wire, on your screen.
BCDA· BioCardia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BCDA (BioCardia Inc.) and more on Quantisnow.